Use of HF20 membrane in critically ill unstable low-body-weight infants on inotropic support

Pediatric Nephrology

Volumn 28, Issue 5, 2013, Pages 819-822

  Liu, Isaac Desheng ^a   Ng, Kar Hui ^a,b   Lau, Perry Yew Weng ^a   Yeo, Wee Song ^a   Koh, Pei Lin ^a   Yap, Hui Kim ^a,b  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Acute kidney injury; Continuous renal replacement therapy; HF20; Infant

Indexed keywords

BICARBONATE; CREATININE; HEPARIN; INOTROPIC AGENT; PHOSPHORUS; POLYARYLETHERSULFONE; POLYMER; POTASSIUM; UNCLASSIFIED DRUG; UREA;

ACUTE KIDNEY FAILURE; ARTICLE; BICARBONATE BLOOD LEVEL; CASE REPORT; CONTINUOUS RENAL REPLACEMENT THERAPY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DIALYSIS MEMBRANE; ELECTROLYTE DISTURBANCE; EXTRACORPOREAL OXYGENATION; HEMODYNAMICS; HUMAN; INFANT; INFANT DISEASE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; UREA BLOOD LEVEL;

ACUTE KIDNEY INJURY; ARTERIAL PRESSURE; BODY WEIGHT; CARDIOTONIC AGENTS; CRITICAL ILLNESS; EQUIPMENT DESIGN; EXTRACORPOREAL MEMBRANE OXYGENATION; HEMODIAFILTRATION; HEMODYNAMICS; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MEMBRANES, ARTIFICIAL; MULTIPLE ORGAN FAILURE; POLYMERS; SULFONES; TREATMENT OUTCOME;

EID: 84880573381     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2394-3     Document Type: Article

References (8)

1. Brophy PD, Mottes TA, Kudelka TL, McBryde KD, Gardner JJ, Maxvold NJ, Bunchman TE (2001) AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis 38:173-178
2. Hackbarth RM, Eding D, Gianoli Smith C, Koch A, Sanfilippo DJ, Bunchman TE (2005) Zero balance ultrafiltration (Z-BUF) in blood-primed CRRT circuits achieves electrolyte and acid-base homeostasis prior to patient connection. Pediatr Nephrol 20:1328-1333
3. Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, Hackbarth R, Somers MJ, Baum M, Symons JM, Flores FX, Benfield M, Askenazi D, Chand D, Fortenberry JD, Mahan JD, McBryde K, Blowey D, Goldstein SL (2010) Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 55:316-325
4. Rödl S, Marschitz I, Mache CJ, Koestenberger M, Madler G, Zobel G (2011) Continuous renal replacement therapy with Prismaflex HF20 disposable set in children from 4 to 15 kg. ASAIO J 57:451-455
5. Symons JM, Brophy PD, Gregory MJ, McAfee N, Somers MJ, Bunchman TE, Goldstein SL (2003) Continuous renal replacement therapy in children up to 10 kg. Am J Kidney Dis 41:984-989
6. Rödl S, Marschitz I, Mache CJ, Koestenberger M, Madler G, Rehak T, Zobel G (2011) One-year safe use of the Prismaflex HF20(®) disposable set in infants in 220 renal replacement treatment sessions. Intensive Care Med 37:884-885
7. Santiago MJ, López-Herce J (2011) Prismaflex HF20 for continuous renal replacement therapy in critically ill children. Artif Organs 35:1194
8. Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth R, Blowey D, Bunchman TE, Brophy PD, Symons J, Chua A, Flores F, Somers MJ (2012) Continuous renal replacement therapy for children ≤10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr. doi: 10.1016/j.jpeds.2012.08.044